TNSN05054A1 - Precurseur de medicament inhibiteur de beta-lactamase - Google Patents
Precurseur de medicament inhibiteur de beta-lactamaseInfo
- Publication number
- TNSN05054A1 TNSN05054A1 TNP2005000054A TNSN05054A TNSN05054A1 TN SN05054 A1 TNSN05054 A1 TN SN05054A1 TN P2005000054 A TNP2005000054 A TN P2005000054A TN SN05054 A TNSN05054 A TN SN05054A TN SN05054 A1 TNSN05054 A1 TN SN05054A1
- Authority
- TN
- Tunisia
- Prior art keywords
- beta
- mammal
- present
- lactam antibiotic
- lactamase inhibitor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D499/21—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D499/44—Compounds with an amino radical acylated by carboxylic acids, attached in position 6
- C07D499/48—Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Des précurseurs médicamenteux de sulfone d'acide 6- beta-hydroxyméthlpénicillanique ayant la structure dans laquelle R représente H ou un groupe méthyle, et leurs produits de solvatation sont décrits. Il est décrit également des compositions pharmaceutiques comprenant un précurseur médicamenteux de la présente invention, ou un de ses produits de solvatation, un antibiotique béta-lactame facultatif et au moins un support pharmaceutiquement acceptable. Il est est décrit en outre une méthode pour accroître l'efficacité thérapeutique d'un antibiotique béta-lactame chez un mammifère en administrant une quantité efficace d'antibiotique béta-lactame et une quantité, a effet d'augmentation d'efficacité, d'un précurseur médicamenteux de la présente invention ou d'un de ses produits de solvatation. Il est décrit en outre une méthode pour le traitement d'une infection bactérienne chez un mammifère en administrant une quantité thérapeutiquement efficace d'une composition pharmaceutique de la présente invention à un mammifère nécessitant un tel traitement.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40564002P | 2002-08-23 | 2002-08-23 | |
PCT/IB2003/003582 WO2004018484A1 (fr) | 2002-08-23 | 2003-08-11 | Promedicament inhibiteur de beta-lactamase |
Publications (1)
Publication Number | Publication Date |
---|---|
TNSN05054A1 true TNSN05054A1 (fr) | 2007-05-14 |
Family
ID=31946909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TNP2005000054A TNSN05054A1 (fr) | 2002-08-23 | 2005-02-23 | Precurseur de medicament inhibiteur de beta-lactamase |
Country Status (31)
Country | Link |
---|---|
US (1) | US7091197B2 (fr) |
EP (1) | EP1534717B1 (fr) |
JP (1) | JP2005539037A (fr) |
KR (1) | KR20050037583A (fr) |
CN (1) | CN1688589A (fr) |
AP (1) | AP2005003231A0 (fr) |
AR (1) | AR041028A1 (fr) |
AT (1) | ATE349452T1 (fr) |
AU (1) | AU2003250489A1 (fr) |
BR (1) | BR0313683A (fr) |
CA (1) | CA2494953A1 (fr) |
DE (1) | DE60310733D1 (fr) |
EA (1) | EA007540B1 (fr) |
EC (1) | ECSP055625A (fr) |
GT (1) | GT200300179A (fr) |
HR (1) | HRP20050162A2 (fr) |
IL (1) | IL166719A0 (fr) |
IS (1) | IS7693A (fr) |
MA (1) | MA27387A1 (fr) |
MX (1) | MXPA05001446A (fr) |
NO (1) | NO20051497L (fr) |
NZ (1) | NZ538340A (fr) |
OA (1) | OA12909A (fr) |
PA (1) | PA8579701A1 (fr) |
PE (1) | PE20040899A1 (fr) |
PL (1) | PL375988A1 (fr) |
TN (1) | TNSN05054A1 (fr) |
TW (1) | TWI250162B (fr) |
UY (1) | UY27947A1 (fr) |
WO (1) | WO2004018484A1 (fr) |
ZA (1) | ZA200501513B (fr) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0410936A (pt) * | 2003-06-05 | 2006-06-27 | Pfizer Prod Inc | pró-fármaco inibidor da beta-lactamase |
US20060105941A1 (en) * | 2004-11-12 | 2006-05-18 | Allergan, Inc. | Mixed antibiotic codrugs |
WO2007012319A1 (fr) * | 2005-07-29 | 2007-02-01 | Sigma-Aldrich Production Gmbh | Melanges lc/ms contenant des additifs ionisants |
WO2010118968A1 (fr) | 2009-04-16 | 2010-10-21 | Nicox S.A. | Dérivés d'aspirine donneurs de no |
WO2013056163A1 (fr) * | 2011-10-14 | 2013-04-18 | The Regents Of The University Of California | Inhibiteurs de bêta-lactamase |
CA2860672A1 (fr) * | 2012-01-06 | 2013-07-11 | University Of South Florida | Compositions, procedes d'utilisation et procedes de traitement |
CN109422765B (zh) * | 2017-09-05 | 2020-08-28 | 香港理工大学深圳研究院 | C类β-内酰胺酶抑制剂及其制备方法和应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE34011B1 (en) | 1969-03-13 | 1975-01-08 | Leo Pharm Prod Ltd | New penicillin esters |
IE34019B1 (en) | 1969-03-18 | 1975-01-08 | Leo Pharm Prod Ltd | New semi-synthetic penicillin esters |
GB1267936A (en) | 1969-05-28 | 1972-03-22 | Beecham Group Ltd | DERIVATIVES OF alpha-AMINOPENICILLINS |
US3957764A (en) | 1969-11-11 | 1976-05-18 | Lovens Kemiske Fabrik Produktionsaktieselskab | 6-aminopenicillanic acid derivatives |
US3862181A (en) | 1970-10-28 | 1975-01-21 | Squibb & Sons Inc | Process for preparing cephalosporins |
GB1315566A (en) | 1970-11-06 | 1973-05-02 | Leo Pharm Prod Ltd | Penicillanic acid derivatives |
CA996929A (en) | 1971-04-05 | 1976-09-14 | Kohzi Nakano | Acyloxyalkyl ester derivatives of penicillin |
GB1433131A (en) | 1972-03-13 | 1976-04-22 | Astra Laekemedel Ab | Penicillins |
GB1426717A (en) | 1972-03-13 | 1976-03-03 | Astra Laekemedel Ab | Penicillins |
US4397783A (en) | 1979-03-05 | 1983-08-09 | Pfizer Inc. | Process for converting 6,6-disubstituted penicillanic acid derivatives to the 6-β-congeners |
DE2927004A1 (de) * | 1979-07-04 | 1981-05-27 | Bayer Ag, 5090 Leverkusen | Penicillansaeure-1,1-dioxide, ihre herstellung und ihre verwendung als arzneimittel als arzneimittel |
US4287181A (en) * | 1979-10-22 | 1981-09-01 | Pfizer Inc. | Derivatives of 6β-hydroxyalkylpenicillanic acids as β-lactamase inhibitors |
US4432970A (en) | 1979-11-23 | 1984-02-21 | Pfizer Inc. | 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors |
GB2076812A (en) * | 1980-05-22 | 1981-12-09 | Ciba Geigy Ag | Penam-dioxide compounds, processes for their manufacture, and their use |
JPS5849387A (ja) | 1981-09-17 | 1983-03-23 | Sankyo Co Ltd | 7−メトキシセフアロスポリン化合物およびその製法 |
AU559689B2 (en) * | 1981-09-22 | 1987-03-19 | Kureha Kagaku Kogyo K.K. | Penicillin derivative |
US4406887A (en) | 1981-10-13 | 1983-09-27 | Bristol-Myers Company | Method for treating resistant bacteria including anaerobes |
US4428935A (en) * | 1982-05-24 | 1984-01-31 | Pfizer Inc. | Penicillanic acid dioxide prodrug |
US4521533A (en) | 1984-07-12 | 1985-06-04 | Pfizer Inc. | Salts of 6-alpha-(aminomethyl)penicillanic acid 1,1-dioxide esters and beta-lactam antibiotics |
DE3901405A1 (de) | 1989-01-19 | 1990-07-26 | Hoechst Ag | Cephalosporinderivate und verfahren zu ihrer herstellung |
JPH03206038A (ja) | 1990-01-08 | 1991-09-09 | Yoshitomi Pharmaceut Ind Ltd | 抗菌剤 |
GB9001405D0 (en) | 1990-01-22 | 1990-03-21 | Leo Pharm Prod Ltd | New intermediates,their production and use |
GB9208492D0 (en) | 1992-04-16 | 1992-06-03 | Glaxo Spa | Heterocyclic compounds |
BRPI0410936A (pt) | 2003-06-05 | 2006-06-27 | Pfizer Prod Inc | pró-fármaco inibidor da beta-lactamase |
-
2003
- 2003-08-06 PA PA20038579701A patent/PA8579701A1/es unknown
- 2003-08-11 CN CNA038243164A patent/CN1688589A/zh active Pending
- 2003-08-11 EP EP03792574A patent/EP1534717B1/fr not_active Expired - Lifetime
- 2003-08-11 WO PCT/IB2003/003582 patent/WO2004018484A1/fr active IP Right Grant
- 2003-08-11 KR KR1020057002983A patent/KR20050037583A/ko active IP Right Grant
- 2003-08-11 AU AU2003250489A patent/AU2003250489A1/en not_active Abandoned
- 2003-08-11 CA CA002494953A patent/CA2494953A1/fr not_active Abandoned
- 2003-08-11 PL PL03375988A patent/PL375988A1/xx unknown
- 2003-08-11 JP JP2004530453A patent/JP2005539037A/ja not_active Abandoned
- 2003-08-11 OA OA1200500051A patent/OA12909A/en unknown
- 2003-08-11 NZ NZ538340A patent/NZ538340A/en unknown
- 2003-08-11 AP AP2005003231A patent/AP2005003231A0/xx unknown
- 2003-08-11 BR BR0313683-3A patent/BR0313683A/pt not_active IP Right Cessation
- 2003-08-11 DE DE60310733T patent/DE60310733D1/de not_active Expired - Lifetime
- 2003-08-11 EA EA200500398A patent/EA007540B1/ru unknown
- 2003-08-11 MX MXPA05001446A patent/MXPA05001446A/es unknown
- 2003-08-11 AT AT03792574T patent/ATE349452T1/de not_active IP Right Cessation
- 2003-08-19 PE PE2003000840A patent/PE20040899A1/es not_active Application Discontinuation
- 2003-08-21 AR ARP030103023A patent/AR041028A1/es unknown
- 2003-08-21 UY UY27947A patent/UY27947A1/es not_active Application Discontinuation
- 2003-08-22 TW TW092123156A patent/TWI250162B/zh not_active IP Right Cessation
- 2003-08-22 GT GT200300179A patent/GT200300179A/es unknown
- 2003-08-25 US US10/648,408 patent/US7091197B2/en not_active Expired - Fee Related
-
2005
- 2005-02-07 IL IL16671905A patent/IL166719A0/xx unknown
- 2005-02-10 IS IS7693A patent/IS7693A/is unknown
- 2005-02-21 ZA ZA200501513A patent/ZA200501513B/en unknown
- 2005-02-21 HR HR20050162A patent/HRP20050162A2/xx not_active Application Discontinuation
- 2005-02-23 EC EC2005005625A patent/ECSP055625A/es unknown
- 2005-02-23 TN TNP2005000054A patent/TNSN05054A1/fr unknown
- 2005-02-23 MA MA28119A patent/MA27387A1/fr unknown
- 2005-03-21 NO NO20051497A patent/NO20051497L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TNSN05054A1 (fr) | Precurseur de medicament inhibiteur de beta-lactamase | |
US11020414B2 (en) | Antimicrobial compositions with cysteamine | |
EP1879655B1 (fr) | Combinaison pharmaceutique comprenant un antibactérien et une substance active choisie parmi le carvéol, le carvacrol, l'alpha-ionone, le beta-ionone, et le thymol | |
MA27389A1 (fr) | Derives de benzimidazole nouveaux utiles comme agents antiproliferatifs. | |
MA27347A1 (fr) | Inhibiteurs de protease du vih, compositions les contenant, leurs utilisations pharmaceutiques et matieres pour leur synthese | |
EA200701869A1 (ru) | Пептидомиметические ингибиторы протеазы | |
US8592473B2 (en) | Triazol compounds for treating biofilm formation | |
EP0222834A1 (fr) | Traitement de la dyspepsie non ulcereuse avec des sels de bismuth | |
TNSN05037A1 (fr) | Derives heterobiaryliques servant d'inhibiteurs de metalloproteinases de matrice | |
JP2021503497A (ja) | 安定したアスコルビン酸組成物およびそれを使用する方法 | |
MA27762A1 (fr) | Utilisation de derives de 10-hydroxy-10, 11-dihydrocarbamazepine pour le traitement de troubles affectifs | |
CA2145521A1 (fr) | Methode et composition pour le traitement de la maladie de parkinson | |
FR2918571B1 (fr) | Compositions antibiotiques a base d'huiles essentielles prophylaxie et traitement d'infections nosocomiales | |
EP3829299A1 (fr) | Compositions de bismuth-thiol et méthodes de traitement de plaies | |
ATE246192T1 (de) | Ethyliden-derivate tricyclyscher carbapenems | |
BR9503572A (pt) | Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença | |
EP0437128B1 (fr) | Utilisation des dérivés des fluoroquinolones pour le traitement de la pneumonie à Pneumocystis carinii | |
ATE185803T1 (de) | N-hydroxy-harnstoff-derivate als entzündunghemmende mittel | |
JP2006504404A5 (fr) | ||
MA26744A1 (fr) | Polymorphes d'un chlorhydrate d'azo-bicyclo-2,2,2-oct-3-ylamine cristallins et compositions pharmaceutiques les contenant | |
Schwalm et al. | Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment | |
US7153826B2 (en) | Treatment of rosacea | |
MXPA05012895A (es) | Profarmaco inhibidor de beta-lactamasa. | |
WO1999066930A1 (fr) | Compositions et methodes de traitement d'une cholesterolemie elevee | |
MA57215B1 (fr) | Composés comprenant un nitrile comme antiviraux pour le traitement d'une infection à coronavirus |